diagnostics
Health 2.0 Conference cofounders Matthew Holt and Indu Subaiya look back at notable digital health funding developments and look ahead at what will come next.
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.